Regulations for Pharmaceuticals Post Brexit

October 5th, 2020|0 Comments

The European Commission has published a Communication to prepare for the end of the transition period. The document is appropriately entitled "Getting ready for changes - Communication on readiness at the end [...]

Complying with new GDP requirements

September 30th, 2020|0 Comments

In an ever changing and complex industry the role of the Responsible Person has developed and grown over the past 10 years as the focus of regulatory bodies have placed a higher [...]

QP Responsibilities

September 29th, 2020|0 Comments

MIAS Pharma provides QP services for commercial and investigational medicinal products. Our QPs have experience in oversight and release of multiple types of products. Each type of product has it's own specific [...]

2109, 2020

Pharma Industry Awards 2020

September 21st, 2020|General News|

We’re pleased to announce that MIAS Pharma Ltd has been shortlisted for Pharma Supplier of the Year in this years Pharma Industry awards. We look forward to a great evening and catching [...]

1803, 2020

A Message from MIAS Pharma (COVID – 19)

March 18th, 2020|Uncategorised|

I wish to update you on MIAS Pharma ltd position regarding COVID-19. The World Health Organisation formally declared COVID-19 a pandemic, and the European Centre for Disease Prevention and Control (ECDC) updated its guidelines around [...]

Load More Posts

Ready to Talk

Go to Top